Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Wednesday, July 1

PS S T A 114315

31124 Prolonged suppression of HIV-1 viremia results in profound but
incomplete enhancement ofanti-HIV-1 CTLm responses in advanced
infection
Charles Rinaldo*;X.L. Huang;Z. Fan;J. Liebmann; D. McMahon;
S. Riddler; J. Mellors, USA
31125 Rare occurrence of CTL escape mutations in HIV-1 infection
Alicja Trocha*; K. Hartmann; S. Kalams; B. Walker; R. Johnson, USA
31126 Analysis of LPS-mediated inhibition of HIV-1 infection of macrophages:
p38 MAPK is the critical regulator
Michael Bukrinsky*; N. Reiling; G. Zybarth; 6. Franchin; B. Sherry, USA
31127 New HLA-All HIV-1 subtype E cytotoxic T lymphocyte (CTL) epitopes
identified in studies of Thai HIV-infected female sex workers
Kyle Bond*; B. Sriwanthana; T W Hodge; C.R Pau; A.S. Degroot;
B.M. Jesdale; TD. Mastro; N.L. Young; K. Limpakarnsanarat;
J.M. McNicholl, USA
31128 Cross-Clade cytotoxic T cell response to HIV-1 proteins among HLA
disparate North Americans and Thais
Julia Lynch*; M. Desouza; M. Robb; S. Nitayaphan; L. Markowitz;
D. Birx; J. Cox, USA
31129 Oral inoculation with HIV-2 elicits a Gag-specific cytotoxic T-cell
response in juvenile but not neonatal macaques
Arnd Martin Herz*; John Lynch; M.N. Robertson; A. Schmidt;
B. Kennedy; L. Kuller; WR. Morton; RD. Greenberg, USA
31130 Control of HIV replication requires virus-specific helper and CTL
function and levels of CTL activity are in equilibrium with viral burden
Spyros Kalams*; S.P Buchbinder; M.J. Billingsley; E.S. Rosenberg;
N. Jones; A.K. Trolha; B.D. Walker, USA
31131 Class I MHC polymorphism and mother to child HIV-1 transmission
in Kenya
Kelly S. Macdonald*; Jose Castillo; E. Embree Joanne; Simon Njenga;
J.D. Nagelkerke Nicolas; Irene Ngatia; Zeena Mohammed, Canada
31132 HIV-specific cytotoxic T lymphocytes (CTL) in HIV-1 infected children:
CTL recognition of various HIV clades
Yves Riviere*; F Bus Eyne; M.L. Chaix; B. Fleury; S. Blanche; C. Rouzioux,
France
31133 Increased levels of b-chemokines and antigen specific T-cell
proliferation in HIV-2 exposed non-infected individuals in GuineaBissau
Siren Andersson*; 0. Larsen; F Dias; A. Naucler; R Aaby;
R. Thorstensson; G. Biberfeld, Sweden, Guinea-Bissau, Denmark
31134 Functional lymphocyte reconstitution and HIV-1 specific T cell
responses during highly active antiretroviral therapy (HAART)
Oscar Pontesilli*; S. Kerkhof-Garde; N.G. Pakker; D.W Notermans;
M.TL. Roos; S.A. Danner; F Miedema, The Netherlands
31135 Recognition of two overlapping CTL epitopes by CTL from
a long-term non-progressing HIV-1 infected individual
Thomas Harrer*; E. Harrer; P Barbosa; R. Wagner;M. Feinberg;
S. Buchbinder; B.D. Walker, Germany
31136 Phenotypic characterisation ofT-cell expansions in HIV-infection
Angel Jaramillo*; J.. Zaunders; A.D. Kelleher; D.A. Coope, Australia
31137 Cytotoxlc T lymphocytes (CTL) recognition of drug-induced variants

in HIV-1 reverse transcriptase
Brigitte Autran*;J. Duntze; A. Samri; G. Haas; C. Katlama; P Debre, France

31138 Cytotoxic T lymphocytes and viral load in HIV-infected children over five
years of age: Influence of CCR5 genotype and antiretroviral treatment
Florence Buseyne*; G. Janvier; M. Burgard; D. Scoot-Algara; J.P Teglas;
S. Blanche; K Riviere, France
31139 Cross-clade HIV-1 specific cytotoxic T lymphocyte (CTL) activity in
HIV-1-infected Ugandan adults
Catherine Othieno*; H. Coo; M. Okello; E. Katongole-Mbidde;
P Mugyenyi; B. Walker; J. Ellner, Uganda
31140 Enhanced production of monocyte-derived suppressive factors by HIVexposed, uninfected (EU) individuals
Salvatore T Butera*; Thomas M. Folks; TL. Pisell; TW Hodge;
K. Limpakarnjanarat; TD. Mastro, USA
31141 Effect of HIV-1 infection on chemokine receptor expression in
CD4+ tetanus toxoid specific T cells
Silvia Ratto-Kim*;J. Mascola; A. Rice; S. Frankel; D. Birx, USA
31142 SpecificT-cell responses in HIV-infected patients after highly
active antiretroviral treatment (HAART)
Ann-Charlotte Leandersson*; G. Bratt; M. Fredriksson; J. Hinkula;
E. Sandstr6m; B. Wahren, Sweden
31143 Protection of HIV-exposed uninfected individuals appears to be
mediated by a CD8+ cell anti-HIV response
Sharon Stranford*;. Skurnick; D. Louria; D. Osmond; S. Y Chang;
G. Ferrari; J.A. Levy, USA
31144 HIV specific immunity in HIV unexposed seronegative Ethiopians
Alexander Kalinkovich*; Z. Weisman; S. Zlotnikov; S. Bar-Yehuda;
A. Fink; Z. Bentwich, Israel
31145 SIV-specific cytotoxic T lymphocytes induced by DNA immunization
Michael Robertson*; S. Mossman; J.B. Lynch; K. Watanabe;
RD. Greenberg; N.L. Haigwood, USA
31146 Study of immunological profil in HIV-exposed seronegative subjects
Bouchra Zerhouni; N. Berra; T Saint Marc; J.-C Tardy; D. Makhloufi;
J.-M. Livrozet; J.-L. Touraine, France
31147 Immune activation markers and chemokine receptor 5 (CCRS)
genotype in highly exposed but persistently seronegative female
sex workers in Abidjan, Cite d'lvoire
Stephania Koblavi-Deme*;J. Nkengason; C. Maurice; RD. Ghys;
M. Maran; K.L. Ya; S.Z. Wiktor; A.E. Greenberg; M. Parmentier;
L. Kestens, COte d'lvoire
31148 New anti-HIV function: RANTES activity via CCR3 is required for
specific T cell cytotoxicity
Fabienne Hadida*; VV Vieillard; B.A. Autran; I.C.L. Clark-Lewis;
N.B. Baggiolini; RD. Debre, France
31149 Cytotoxic T lymphocytes (CTL) from HIV-2 positive patients
frequently cross-react with different HIV-lgag subtypes
Fatim Cham*; A. Bertoletti; 5. McAdam; 5. Rowland-lones; L Corrah;
K. Ariyoshi; H. Whittle, Belgium
31150 Generation of HIV-epitope-specific CTL by HIV-peptide pulsed,
allogeneic dendritic cells
Smriti Kundu*; M. Dupuis; C. Benike; E. Engleman; L Merigan, USA
31151 P24 antigen stimulated immune responses after treatment with
an inactivated gp 120-depleted HIV-1 immunogen (REMUNET)

in HIV-1 seropositive subjects
Ronald Moss*; M.R. Wallace; R Lanza; WK. Giermakowska;
FC. Jensen; G. Theofan; C. Chamberlin; S.P Richieri; DJ. Carlo, USA

134

12th World AIDS Conference Geneva